Business
Business Archives » 2011 & 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998
December 19, 2005
Business Concentrates
2005 Year In Review
Industry recovery continued in 2005, but it was hindered by high energy prices and disasters.
Finding Magic In Polymer R&D
Dutch Polymer Institute meeting spotlights research into new technology and applications.
Hovione InMacau
Pharmaceutical ingredient plant is an important part of firm's global network.
December 12, 2005
Business Concentrates
Sharing Drug Data
Research chemists and clinicians hammer out a 'bench-to-bedside' information support network.
Aiming For Number One
Planned cracker will place SABIC's European arm among region's top polyolefin makers.
December 5, 2005
Business Concentrates
Pharma Reformulates
Sales grew in the past year, but the pharmaceutical industry saw many major products come under fire and was challenged in moving new ones forward.
PerkinElmer Hones Life Sciences Plan
With sale of fluid sciences business under way, instrument maker focuses on life sciences.
Steady R&D For Agchem
Discovery and development account for half of spending by top crop protection chemical companies.
C&EN Talks With Agnes Varis
A champion for the generic drug industry deftly mixes business and Democratic politics.
November 28, 2005
Business Concentrates
Red Sun Matures
Contract manufacturers emphasize the need for greater process efficiency via breakthrough chemistry.
Profiting From Innovation
Research And Development leaders say they still have plenty of tricks up their sleeves to develop new products.
November 21, 2005
Business Concentrates
CPhI Promises A High-Tech Comeback
Contract manufacturers emphasize the need for greater process efficiency via breakthrough chemistry.
Regulations
Europe Makes Manufacturing Compliance An Obligation.
Chemical Earnings Growth Slows
Hurricanes and high costs dampen third-quarter results for most U.S. firms.
Pfizer's Troubles Pull Down Drugmakers
Top U.S. company joins Merck and Bristol-Myers Squibb in posting third-quarter sales declines.
Biotech Earnings Jump In Quarter
Genentech leads the biopharmaceutical sector to a strong third quarter.
An Industry Siesta Quarter
The chemical industry in Mexico is trying to recover from a major setback in development.
November 14, 2005
Business Concentrates
Shin-Etsu Reloaded
Plastics and silicon wafer giant spends billions in U.S. and Japan to bolster core businesses.
Specialty Chemicals
Clean Chemistry
Approaches abound for replacing perchloroethylene in dry cleanings.
Fresh Faces
The often-fickle consumer drives the market for cosmetics preservatives.
Staying Flexible
Phthalate ester plasticizers hold their own despite intense scrutiny.
Phthalate Assessed
New report by safety panel reinforces conclusions from five years ago.
November 7, 2005
Business Concentrates
Fertilizer Business
Prices and profits are increasing, but some worry that products have already peaked.
Barry Siadat
C&EN talks with Arsenal Capital's managing director about private equity's role in specialty chemicals.
October 31, 2005
Business Concentrates
U.S. Contract Research
Chemistry services firms try to maneuver in new global environment.
Asian Contract Research
Indian and Chinese firms enjoy flourishing business growth.
October 24, 2005
Business Concentrates
Fine Chemicals
European producers continue to roll with the punches.
Oxyrane
New South African firm develops chiral biocatalysts.
a-Olefins
Producers face chronic oversupply problems.
October 17, 2005
Business Concentrates
ElastomersBounce Back
Commodity synthetic rubber makers have been stretching profits because of improved sales, but are now strugglingwith high raw material prices.
Stretchable Plastics Continue To Expand
Ease of use and better processing boost acceptance of thermoplastic elastomers.
Within REACH
Debate on proposed regulations set to take place preoccupies chemical conference in Europe.
Third-Quarter Stocks
Chemical and pharmaceutical stock prices fell, while biotech share prices rose.
October 10, 2005
Business Concentrates
Czech Biotech
Changing atmosphere nourishes industry.
Genomics Gold Mine
LineaGen makes Utah population database available to drug researchers.
Investing in China
BASF and Sinopec open a huge chemical complex.
October 3, 2005
Business Concentrates
Shot In The Arm
Vaccines gain renewed importance in the pharmaceutical pipeline.
Coolants
Global warming concerns threaten market for fluorocarbons.
Cambrios
Inspired by biology, start-up company offers new approaches to electronics manufacturing.
Insights
Despite dramatic industry growth last year, chemical prices and production show little growth this year.
September 26, 2005
Pollution In China
Violent villager uprisings over industrial pollution force China to face its environmental problems.
SOCMA Conference
Organization will drop The Responsible Care program in favor of its own initiative.
Traveling Exhibition
Art and alchemy will be the focus of a Chemical Heritage Foundation and Philadelphia Museum of Art show in 2009.
Business Concentrates
September 19, 2005
Business Concentrates
Growing Agchem R&D
Agrochemical researchers are maintaining their crop protection arsenals by using tools developed by the pharmaceutical industry.
Spore Wars
Study tracks economic benefits of using fungicides to combat ubiquitous pests.
Risking IP in China
International agrochemical companies boost their presence in China despite threat of piracy.
Symyx Technologies
Firm's audacious goal is to transform every step in the scientific experimentation process.
September 12, 2005
Business Concentrates
Spotlight On Polymers
Flat demand and high energy prices mark a setback versus a year ago, but producers believe a comeback looms.
Styrenics Maker Seeks Market Niche
ABS producers have taken hits from Asia and other polymers, but they still have a sizable business.
Helsinn
Firm focuses on "exclusive" manufacturing and advanced synthesis of pharmaceutical ingredients.
September 5, 2005
Diesel Fuel
Additive suppliers eye market in advance of new regulations next year.
Insights
Chinese private sector grows but hasn't shaken off state controls.
Business Concentrates
August 29, 2005
Biopharmaceuticals
Powering a wave of new drug technologies is a resurgence of medicinal chemistry.
Bird Flu Drug
If an avian flu pandemic breaks out, Roche may not be able to meet the demand for its antiviral Tamiflu.
Business Concentrates
August 22, 2005
Methane Hydrates
Potential source of natural gas is vast, but recovery poses major challenges.
Chemical Earnings
Solid growth continues in the second quarter.
Pharma Earnings
European drugmakers did better than their U.S. counterparts in the second quarter.
Biotech Earnings
The biotechnology industry's profitability improved sharply during the quarter.
Business Concentrates
August 15, 2005
Business Concentrates
August 8, 2005
Semiconductors
Meeting highlights efforts to supply exotic materials for fast-growing markets.
Midwest Attraction
Cincinnati hopes to become a biotech hub.
Business Concentrates
August 1, 2005
High Fiber
Defense demands drive the ramp-up of high-performance fiber capacity.
European Pharma
Second-quarter results at four of Europe's major drugmakers are quite favorable.
Business Concentrates
July 25, 2005
Molecular Imaging
Firms integrate new imaging agents and technologies into their drug development efforts.
Chemtura
Robert Wood has high aspirations for his new firm, one of the largest specialty chemical companies in the U.S.
Chemical Brokers
Manufacturers' reps face many changes in the business of supplying chemicals to the pharmaceutical industry.
Business Concentrates
July 18, 2005
Global Top 50
Top three firms maintain positions as rising oil prices and globalization affect the world's chemical industry.
2nd-Quarter Stocks
Chemical stock prices generally fell, while pharmaceutical and biotech share prices rose.
Polypeptide Labs
Pharmaceutical chemicals firm carves a niche in peptide production.
Business Concentrates
July 11, 2005
Facts & Figures
Chemical industry data for 2004 show a significant turnaround for producers around the world, as production volumes increase.
CHEMSPEC
Trade show gives new companies an opportunity to shine.
New Owner
Family-owned PQ Corp. is sold to JP Morgan, whose plan is to maximize growth and earnings.
Economic Expansion
Chemical firms at industry conference outline strategies for the future.
Business Concentrates
July 4, 2005
JSR Corp.
Electronic materials business helps Japanese synthetic rubber firm stay ahead.
Jack Gerard
C&EN talks with ACC?s new president and CEO.
Business Concentrates
June 27, 2005
Thinning Flat Panels
Materials suppliers are thrilled by the flat-panel industry's growth, but are under pressure to trim back on costs.
Gas Delivery
Arguing Over The Safety Of Fluorine.
Forging The Way To High-K Dielectrics
Numerous electronic chemical producers are ready to supply hafnium-based materials.
Ancillary Chemistry
High-K Dielectrics Require New Etching Techniques.
Data Storage In 3-D
Holographic data storage has made enormous technical advances, but still awaits a market.
Image Campaign
American Chemistry Council will try to improve public opinion about the chemical industry.
Air Liquide
French firm looks to extend its global R&D network.
Business Concentrates
June 20, 2005
Business Concentrates
June 13, 2005
Industry Philanthropy
Corporate citizenship efforts equal a win-win situation for communities and donors.
Scorecard
Annual survey of women in industry management positions shows mixed results.
Women At Work
Women's workplace presence has increased greatly in past 30 years, along with education level.
Sam Cohen
C&EN talks with low-profile chemical entrepreneur about his experiences and lessons learned.
Business Concentrates
June 6, 2005
BiopharmaceuticalS
Biogeneric drug firms position themselves to take advantage of patent expirations for lucrativebiologics, but obstacles abound.
Brand New
Chemical companies seek to define themselves through corporate branding.
Asian Petrochemicals
Feedstocks and slowdown in Chinese demand cast cloud over industry conference.
Business Concentrates
May 30, 2005
Rohm and Haas
CEO Raj Gupta explains company's strategy for achieving long-term prosperity.
Information Technology
Trade shows in Boston include SAP user meeting and biotech IT expo.
Agricultural Chemicals
Bayer CropScience takes lead position in the global crop science industry.
Business Concentrates
May 23, 2005
Chemical Results
Production of chemicals increased and chemical prices skyrocketed, contributing to solid first-quarter earnings growth.
Pharma Results
Most firms posted single-digit gains in sales and earnings, but some large firms saw double-digit gains.
BioPharma Results
A few large companies saw continued strong performance, but most small firms lost money.
Palladium Medal
Former BASF chairman J?rgen Strube is honored for contributions to his company and to the chemical industry.
Business Concentrates
May 16, 2005
Top 50 U.S. Chemical Producers
Sales and operating profits rose dramatically in 2004 for most companies; Dow again leads the ranking.
Cefic
A changing chemical industry prompts pan-European trade group to restructure.
Celanese
Performance-polymers producer makes its third go as a publicly owned firm.
Business Concentrates
May 9, 2005
Information Technology
Rapid development of software and new uses of the Web in business have brought the industry to the point of a generational change in IT.
Unique Company
Private ownership gives Wacker-Chemie the flexibility to make big investments.
Lanxess
Bayer spin-off aims to restructure in light of its loss-making businesses.
Business Concentrates
May 2, 2005
Nanotechnology
The future of nanotech-related firms is brighter than it has been in years past, but venture capitalists still wait for a return on their investments.
Contract Manufacturing
India's Jubilant Organosys focuses on serving other firms in the agro and drug sectors.
Insights
Get ready to lose the war over ownership on the Web.
Business Concentrates
April 25, 2005
Going Public
Huntsman's initial public offering of stock was a success--now the firm is paying off its debts.
Birthday Bash
Chemist and entrepreneur A. V. Rama Rao celebrates with a three-day chemistry symposium.
Cytec Coatings
Ben Van Assche is the force behind firm's enlarged surface specialties unit.
Business Concentrates
April 18, 2005
Specialty Chemicals
Companies reassess their R&D operations and adopt new strategies for managing their specialty portfolios.
1st-Quarter Stocks
Chemical performance improved while drug and biotech indexes fell.
Petrochemical Meeting
Annual event focused on long-term concerns.
Business Concentrates
April 11, 2005
Sunscreens
Manufacturers are frustrated by FDA's slow turnaround times for product approvals and UV-A testing protocols.
New Business Model
Solvias shifts its developmental focus to chiral chemistry and catalysis.
Chemical Industry Productivity
Output per workhour increased in 2004, outpacing that of last year.
Business Concentrates
- Boehringer Ingelheim to build phenylephrine plant in the U.S
- Dow is developing styrene route
- Ciba opens R&D center
- Genentech, Curis add to alliance
- Grace takes concrete action
- PQ shuffles management
- Monsanto sells Enviro-Chem
- Dow expands global glycols
- Textile fibers venture planned
- Solvay 'home' with bicarb production
- Honeywell lets waxes slip
- Three deals are completed
- Lanxess sells line to Chinese
- Chlorine kills 29 in China
- Employment rises slightly
- Teijin exits fibers venture
- Rhodia plans China diphenols
- Business Roundup
April 4, 2005
Pharma Outsourcing
Three case studies of relationships show how firms respond to constant change in the biotech industry.
Nicholas Piramal
Indian drug firm emphasizes custom manufacturing over generics.
Singapore Development
Island nation is working to attract more multinational chemical firms.
Insights
In flaunting its 2004 record income, ExxonMobil showcases the integration of its chemical operations.
Business Concentrates
- Bad and good news for oligo firms
- Agchems help Monsanto, FMC
- Lanxess opens leather lab
- Arch regains DOD contract
- ISP to expand elastomers
- Solutia closing a nylon plant
- Dr. Reddy's in generics pact
- Frontier makes fullerenes in the U.S.
- P&G to build fatty acid unit
- Bayer debuts art for floors
- Monsanto buys Icoria assets
- DIC buys UV coatings firm
- Chemicals aid Sinopec results
- Crompton plans equipment pact
- Business Roundup
March 28, 2005
New Jersey
Overseas fine chemicals companies find the Garden State is a solid base for their U.S. expansions.
Bruker Companies
Firms may share a name and family shareholders, but they have distinct focuses and outlooks.
Business Concentrates
- Pharmaceutical, biotech merger activity picked up in 2004
- ACC names new president
- Crompton sells a business
- Pfizer to sell Michigan plant
- Bayer, Roche in biomarker deals
- India moves on drug patents
- Innovene is new name for BP olefins unit
- Solvay to buy French firm
- Dow boosts cellulosics
- BASF expands nylon capacity
- Chemical prices rise again
- Sterol facility set in Finland
- Japan Tobacco, Gilead in pact
- Petro-Canada buys a plant
- Synthetic silica plant planned
- Business Roundup
March 21, 2005
Petrochemicals
North American producers bounce back from tough times, the Middle East commits to expanding its global role, and Asia becomes an attractive place to build.
Pharma Earnings
European drugmakers outpaced the U.S. in 2004.
Biotech Earnings
Companies averaged double-digit sales and earnings growth.
European Earnings
European chemical firms enjoyed a strong comeback last year.
Business Concentrates
- DuPont boosts new product output
- Sasol expands, draws interest as a takeover
- BASF revamps plasticizers
- DyStar expands in China
- ISP acquires BP BDO plant
- Ferro will restructure
- Firms develop nanocoatings
- Huntsman boosts MDI capacity
- Actelion gets Merck payment
- Epimmune, IDM to combine
- Pact formed to map soybean
- Chemical output rises a little
- Ranbaxy R&D chief departs
- Public-private RNAi effort
- Business Roundup
March 14, 2005
Peptide Drugs
Peptides' activity and specificity are pluses, but high R&D costs and difficult scalability remain hurdles.
Mergers and Acquisitions
Financial buyers lost traction in 2004.
Indian Pharma
India faces limitations as an emerging supplier of pharmaceutical materials and services.
Business Concentrates
- Degussa launches new effort in process intensification
- Dow, Pfizer in expression pact
- J&J to buy TransForm
- Degussa boosts superabsorbents
- Ciba acquires pigment line
- Venture claims H2O2 advance
- Evotec buys back drug unit
- Exxon planning for Singapore
- Asahi settles pricing suit
- Chemical jobs continue to fall
- China gets more fibers
- Itochu teams with Sosei
- Two companies see growth
- Teijin expands specialty fiber
- Business Roundup
March 7, 2005
Patent Rights
Court decisions force Japanese firms to reassess compensation policies for inventive employees.
DSM Revamp
Firm's portfolio transformation program wraps up on a positive note.
Edwin Moses
C&EN talks with European biotech leader about his move to a nonexecutive role.
Insights
Fundamental reasons exist for excluding one-time items from company earnings.
Business Concentrates
- Shin-Etsu continues spending push with methylcellulose hike
- DuPont in TiO2 talks in China
- Sankyo, Daiichi confirm merger
- Dow enters fuel-cell pact
- Solvay boosts Thai affiliate
- Lanxess moves three China projects ahead
- Flexsys sues over patents
- Skin care buy for Engelhard
- P2i coating finds new uses
- BASF slates service center
- Mylan drops bid for King
- Fluorine stars in emissions-cutting scheme
- Ag discovery pacts signed
- DuPont to sell DUSA stake
- Business Roundup
February 28, 2005
Pharmaceutical Business
Big pharma reorganizes clinical trials with high-tech tools and streamlined business processes.
Chemical Earnings
Chemical companies sampled by C&EN finish fifth straight quarter of above-40% earnings increases.
Polyactic Acid
High hopes for commodity polymer derived from corn didn't pan out, but appeal is expected to grow.
Business Concentrates
- Sankyo and Daiichi seen in talks
- Degussa sells fruit business
- Symyx to buy software firm
- Kerr-McGee may sell TiO2 business
- Bayer debuts concept car
- Borden builds plants in Brazil
- MedImmune adds to venture capital fund
- Pfizer buying biotech firm
- Chemical prices are mixed
- Biotage buys Argonaut unit
- Dynea signs NOx agreement
- Partnership tackles quality in nanotech
- Firms invest in Singapore
- Business Roundup
February 21, 2005
Lubrizol
Company's acquisition of specialty chemical maker Noveon looks like a winner.
Glycerin Woes
Flood of biodiesel by-product glycerin worries oleochemical firms.
Japan and the Midwest
After Japanese trade organization helps to forge a biotech alliance with the Midwest.
Business Concentrates
- Jobs to go at SABIC German site
- EMS Group to spin off fine chemicals
- Campbell named ACC chairman
- Amgen halts Phase II study
- Nexen is selling chemical unit
- Sigma-Aldrich buys Degussa's Proligo unit
- Brazil signs with Venezuela on chemicals ...
- ... eyes acrylic plant with Dow
- Arkema forms nanotech pact
- Vertex licenses a cancer drug
- Isis strikes deal with Sarissa
- Production recovers
- Dow mulls more ethanolamines
- Two firms win NIH business
- Another boost to bulletproof fiber at DSM
- Fuller takes Chile charge, forms venture
- Business Roundup
February 14, 2005
Air Products in Asia
Firm seeks to expand while emphasizing safety and ethics.
U.K.'s Millbrook
Up-and-coming instrumentation firm carves out a niche in nanometrology.
Disability Lawsuit
After Anthony Czarnik was terminated for clinical depression, he sued the company he had cofounded, and won.
Business Concentrates
- Norsk Hydro chlorine expansion is part of Europe technology shift
- Profits rise in Japan
- Bayer coating seals stadium
- Reilly eyes spring exit
- BASF invests in encapsulation
- Invitrogen buys again
- BOC buys into hydrogen firm
- Hungary gets expansions
- Takeda buys biotech Syrrx
- Two biotechs plan layoffs
- Yara adds to fertilizers
- Fuji and JSR in LCD projects
- Sumitomo converts plant
- Celanese gets raw materials in Nanjing
- Chemical jobs plummet
- Business Roundup
February 7, 2005
Chemical Spending
Firms are considering investments in capacity and equipment, as well as a boost to R&D budgets.
Informex Review
Life sciences present a challenge that contract chemistry and service firms are ready to meet.
Insights
Huge swings in chemical trade require an explanation.
Business Concentrates
- Huntsman sets price for IPO
- Arkema plans vinyl revamp
- Nova expanding Corunna site
- Dow buys out PBB Polisur
- GE invests big in Spain
- DuPont signs with Icoria
- Cargill renames polymer firm
- Lanxess stock is launched
- Sumitomo boosts LCD presence
- Chemical output slips slightly
- InnoCentive in two new deals
- Mitsubishi ups carbon fiber
- Shire signs with New River
- Business Roundup
January 31, 2005
Pharmaceuticals
India is on the fast track to becoming a global player in the field.
Fuel-Cell Materials
Developers of proton-exchange membranes say their progress is enabling an automotive revolution.
Business Concentrates
- Investors shun Celanese stock offer
- DuPont Dow settles suits
- Solutia exiting acrylic fibers
- Rovers, DuPont still on the go
- Degussa slates China projects
- Danisco to buy Genencor
- Pfizer plans Angiosyn buy
- Dow swaps IP for nanotech investment
- Schering-Plough nabs NeoGenesis
- Chlorine spill cost estimated
- Price climb continues
- Chile studies ethylene plant
- Protein Design buys drug seller
- Pollution spurs Rhodia suit against Sanofi
- Degussa switches MTBE production
- Business Roundup
January 24, 2005
Soaps & Detergents
Firms look for ways to enhance premium products and to adapt their cleaning chemistries to less expensive products sold in the developing world.
Fine Chemicals
France's PCAS hopes to become a contender in the global active pharmaceutical ingredients market.
Business Concentrates
January 17, 2005
Custom Chemicals
Recent painful adjustments have changed the way custom synthesis providers view the marketplace.
Altana Chemie
German company wants to be a leading specialty player in growing niche markets.
Fourth-Quarter Stocks
Chemical stocks performed well in 2004, but biotech and drug sectors lagged behind overall market.
Business Concentrates
January 10, 2005
Business Concentrates
World Chemical Outlook
Global chemical industry continues the economic expansion started in 2004: The U.S., Canada, Asia, and Latin America see strong demand and increasing profits, but Europe's chemical industry lags behind.
January 3, 2005
Business Concentrates
Crompton
New CEO champions ambitious reorganization.
BASF Agreement
Plans are under way to ensure competitiveness of operations at headquarters site.
Start-Up Philanthropy
Amyris Biotechnologies focuses its energies on a nonprofit venture to develop a malaria drug.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © 2011 American Chemical Society